Clinical Study Aiming to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Administration of ZE50-0134 at 5 Dose Levels in Healthy Volunteers
Clinical trial NCT06787131 · COMPLETED
Trial details
- NCT number
- NCT06787131
- Sponsor
- Lomond Therapeutics Holdings, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-21
- Primary completion
- 2025-07-04
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.